Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-08-10

Clinical Trial Update: Phase I Combination w/ Epirubicin [Phase 1]

View source ↗

Summary

This Phase I trial by R-Pharm evaluating a combination with Epirubicin in metastatic breast cancer has completed, with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Epirubicin (epirubicin)

Snippet

Sponsor: R-Pharm | Conditions: Metastatic Breast Cancer | Phase 1 | Status: COMPLETED | Results posted: 2010-08-10